Heart Failure Online 2022 On-demand
Published: 09 May 2022
Part 2 | Session 3 Session 2.3 - Practical Theory and Hot Topics
Part 2 | Session 4 Session 2.4 - Patient Case Revisited: Advanced HF Care
Part 2 | Session 5 Session 2.5 - Practical Theory and Hot Topics
Part 3 | Session 2 Session 3.2 - Practical Theory and Hot Topics
Part 3 | Session 3 Session 3.3 - Live CRT Case
Part 3 | Session 4 Symposium - Making Gains in HFpEF: An Appraisal of Where We Are Now
Part 1 | Session 1 Session 1:1 - Patient Case: The Complex Patient Andrew JS Coats, Shelley Zieroth, Carolyn Lam, Ewa Jankowska, Ileana L Piña
Part 1 | Session 2 Session 1.2 - Practical Theory and Hot Topics Andrew JS Coats, Shelley Zieroth, Javed Butler, Ewa Jankowska, Carolyn Lam, Ileana L Piña
Part 1 | Session 3 Session 1.3 - Patient Case Revisited: Transitioning Care and Monitoring Technology Ileana L Piña, Philipp Lurz, Loreena Hill, Harriette Van Spall, Rajiv Sankaranarayanan
Part 1 | Session 4 Session 1.4 - Practical Theory and Hot Topics Ileana L Piña, Philipp Lurz, Loreena Hill, Harriette Van Spall, Rajiv Sankaranarayanan
Part 1 | Session 5 Symposium - The 2022 ACC Heart Failure Guidelines: What Do They Mean for Your Practice? Andrew JS Coats, Biykem Bozkurt, Mikhail Kosiborod
Heart Failure Online (HFO) is a new innovative virtual event, that brings together a leading international faculty to create a rich, interactive experience to best inform the global heart failure community of the latest developments and advances in clinical practice.
With patient management and outcomes at its core, Course Director Prof Andrew Coats (President of the Heart Failure Association and Professor of Cardiology, University of Warwick, UK) leads an interactive programme of discussion, opinion and case studies focusing on the patient journey.
Note, the live version of this session was CME accredited; this on-demand version is not.
Key Learning Objectives
Following the activities, participants will be able to:
- Select foundational and advanced management strategies in complex patients
- Discuss the validity of using ejection fraction to determine optimal treatment strategies
- Assess the likely impact of health technology on future practice
- Identify the underlying causes of heart failure
- Select appropriate interventional and device-based treatments for treating underlying causes of heart failure
- Assess the impact of the multidisciplinary team on heart failure outcomes
- Discuss the importance of using quality of life and patient self-assessed measures relative to hard clinical end points
- Heart Failure Specialists
- General Cardiologists
- General Practitioners (GPs)
- Nurses, Pharmacists, and other Allied Healthcare Professionals
More from this programme
Day One: Individualising Treatment
Day Two: Complex Phenotypes and Advanced Treatment
Day Three: Beyond Foundational Management
Ileana L Piña
Dr Ileana L Pina is Professor at the Department of Medicine (Cardiology) and Professor in the Department of Epidemiology and Population Health at Montefiore Einstein Center for Heart and Vascular Care, US.
Dr Piña has a particular research and clinical interest in rehabilitation of heart disease in patients with heart failure. She completed a NHLBI HF ACTION trial and is in the process of examining recovery after exercise which could be translated to an additional parameter that may better predict prognosis of outcomes. In addition, there was a R21 to NHLBI to examine Vitamin D levels as another predictor from the HF ACTION database.
Dr Ileana L Pina is an Editorial Board member of Cardiac Failure Review.
Ralph von Bardeleben
Head of the Centre of Structural Heart Disease Interventions and the Heart Valve Centre
Prof Ralph Stephan von Bardeleben is the Head of the Centre of Structural Heart Disease Interventions and the Heart Valve Centre in Mainz, Germany.
Prof Bardeleben is Past-President of the German working group on Echocardiography of the German Society of Cardiology and a member of several medical societies. He serves on the Clinical Program commission and at your region program of the ESC and is a reviewer for several peer-reviewed journals. Newly elected co-editor-in-chief of Echocardiography Journal.
He participates as PI, steering committee member and core laboratory in several medical device trials, including a German Federal Institute for Drugs and Medical Devices (BfArM)-approved first- or early-in-human medical device implant trials.
Director of the Heart Failure and Heart Transplant Clinics
Dr Shelley Zieroth is Professor at the College of Medicine, Max Rady Faculty of Health Sciences, University of Manitoba, as well as Director of the Heart Failure and Heart Transplant Clinics at St. Boniface Hospital in Winnipeg, CA.
She is also Head of the Medical Heart Failure Program for Cardiac Sciences Manitoba. She is involved in several heart failure clinical trials as a PI, National Lead or Executive Committee member. She is the Immediate Past President of the Canadian Heart Failure Society and Co-Chair of the Canadian Cardiovascular Society Heart Failure Guidelines. She serves as Co-Chair of Canada’s largest annual heart failure meeting, HF Update and serves as Scientific Planning Committee Chair for the Canadian Cardiovascular Congress hosted by the Canadian Cardiovascular Society. She is currently President-elect of the Federation of Medical Women of Canada.
Dr Biykem Bozkurt is the Immediate Past President of the Heart Failure Society of America.
Dr Bozkurt is a Professor of Medicine, an advanced heart failure and cardiac transplantation specialist, Medical Care Line Executive (Medicine Department Chair) at the DeBakey VA Medical Center; W.A. “Tex” and Deborah Moncrief, Jr., Chair; Mary and Gordon Cain Chair; Vice-Chair of Department of Medicine; Director of the Winters Center for Heart Failure and Associate Director of Cardiovascular Research Institute at Baylor College of Medicine.
Dr Fabien Praz is an interventional cardiologist at Bern University Hospital, Switzerland. His top areas of expertise are Mitral Valve Regurgitation, Tricuspid Regurgitation, Mitral Stenosis, and Aortic Valve Stenosis.